244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells

The epidermal growth factor receptor (EGFR) is known to play a critical role in non-small cell lung cancer(NSCLC). Several EGFR tyrosine kinase inhibitors(TKIs), such as gefitinib, have been used as effective clinical therapies for patients with NSCLC. Unfortunately, acquired resistance to gefitinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi, Yao, Ke, Shi, Chengcheng, Jiang, Yanan, Liu, Kangdong, Zhao, Song, Chen, Hanyong, Reddy, Kanamata, Zhang, Chengjuan, Chang, Xiaoyu, Ryu, Joohyun, Bode, Ann M., Dong, Ziming, Dong, Zigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792556/
https://www.ncbi.nlm.nih.gov/pubmed/26517520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792556/
https://www.ncbi.nlm.nih.gov/pubmed/26517520

Ejemplares similares